MAP extends its support to high-potential late stage start-ups to build credibility for adoption. Start-ups require systematic commercial and operational evidence for their innovative products and services to de-risk procurers (hospitals, other healthcare facilities etc.) and enable smoother market adoption. MAP has developed a network of partners, each bringing validation expertise across various fields, who will support start-ups in identifying the biggest evidence related gaps that cause a hindrance in their marketability and scalability, and support them in bridging such gaps by designing a holistic study that addresses multiple market segments and multiple gapsIdentifying gaps in evidence:
- MAP network partners will conduct a careful analysis of a technology’s value proposition, results from past pilot studies, customer feedback, business models etc. and identify the evidence gaps that prevent marketability and scalability. Holistic studies can then be designed to fill the identified evidence gaps.
Conducting the study:
- MAP will support start-ups in identifying appropriate test facilities for conducting validation studies in a credible manner
Financing the study:
- Each pilot study is associated with some financial implications which can be source of strain for the start-ups. MAP will facilitate connections for start-ups with financing organizations to unlock funding opportunities.